Status:

WITHDRAWN

CGM/Clarity Use, Glycemic Control and Clinical Outcomes

Lead Sponsor:

University of Maryland, Baltimore

Collaborating Sponsors:

Baltimore VA Medical Center

Conditions:

Diabetes Mellitus

Hyperglycemia

Eligibility:

All Genders

21+ years

Phase:

NA

Brief Summary

The prevalence of Diabetes Mellitus (DM) is rising and more than 30 million of Americans or 9.4% of the US population has DM. Several large scale randomized clinical trials have found that improved gl...

Eligibility Criteria

Inclusion

  • History of Diabetes Mellitus type 2 (DM2) on insulin
  • Uncontrolled glycemic control \[hyperglycemia defined as Hba1c≥9% in the last 3 months or clinically important hypoglycemia (any reported glucose values less than 54 mg/dl) or severe hypoglycemia (low glucose value that led to a severe event characterized by altered mental status and or physical status requiring assistance)\]

Exclusion

  • Subjects that have a history of type 1 DM
  • History of type 2 DM, not treated or required to be treated with basal/bolus insulin (i.e diet only, any combination of non insulin antidiabetic drugs only, basal only insulin or bolus/short acting only insulin, or pre-mixed insulins) as these patients are less likely to benefit from CGM use.
  • Pregnant patients
  • Use of Clarity/ Share or follow applications as telehealth/telemedicine to improve DM management during the last 3 months prior to study entry.
  • Extensive skin changes/disease or allergies that preclude wearing the CGM sensor
  • Significant psychiatric illness or any mental condition rendering the subject incapable of understanding the objectives and potential consequences of the study.
  • Subjects without personal computer and internet network access.

Key Trial Info

Start Date :

November 22 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 22 2024

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT03827434

Start Date

November 22 2024

End Date

November 22 2024

Last Update

November 26 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Baltimore VA Medical Center

Baltimore, Maryland, United States, 21201

CGM/Clarity Use, Glycemic Control and Clinical Outcomes | DecenTrialz